Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
Limited Edition Golden Llama is here! Check out how you can get one. 
Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free!Get your ComboX free sample to test now!
Time Limited Offer: Welcome Gift for New Customers ! Shipping Price Reduction for EU Regions
| Cat. No. | Especies | Descripción del producto | Estructura | Pureza | Característica |
|---|---|---|---|---|---|
| CD9-H5222 | Human | Human CD69 / CLEC2C Protein, His Tag |  |
|
| Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
|---|---|---|---|---|---|---|---|---|---|---|
| Decitabine/Cedazuridine | ASTX-727-LD; ASTX-727-10; E-7727/decitabine; Decitabine/E7727; ASTX-727 | Approved | Astex Pharmaceuticals Inc, National Cancer Institute | INAQOVI, Inaqovi, Inqovi | United States | Myelodysplastic Syndromes | Otsuka Pharmaceutical Co Ltd | 2020-07-07 | Leukemia, Myelogenous, Chronic; Leukemia; Solid tumours; Myelodysplastic Syndromes; Leukemia, Myelomonocytic, Chronic; Neoplasms; Triple Negative Breast Neoplasms; Mesothelioma; Breast Neoplasms; Leukemia, Myeloid, Acute; Glioma; Nervous System Neoplasms; Neurilemmoma | Details |
| Mecobalamin | E-0302 | Approved | Myelogen, Naso B12, NASOCOBAL, Methycobal, 弥尔神, 悦敏兴, RHINOCOBAL, 奇信, 曲力, 弥可保 | Peripheral Nervous System Diseases; Autistic Disorder; Neuritis; Neuralgia; Vitamin B 12 Deficiency; Amyotrophic Lateral Sclerosis; Fibromyalgia | Details | |||||
| Azacitidine | NSC-102816; 5-aza-CR; CC-486; NS-17; U-18496; NEX-18; NEX-18a | Approved | Celgene Corp | 维达莎, Vidaza, Onureg | United States | Myelodysplastic Syndromes | Bristol-Myers Squibb Company | 2004-05-19 | Leukemia, Myeloid, Acute; Immune System Diseases; Prostatic Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Breast Neoplasms; Osteosarcoma; Sarcoma; Brain Neoplasms; Tuberculosis, Pulmonary; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Primary Myelofibrosis; Hepatic Insufficiency; Multiple Myeloma; Lymphoma; Leukemia, Myelomonocytic, Juvenile; Lymphoma, Non-Hodgkin; Thyroid Neoplasms; Lung Neoplasms; Myelodysplastic-Myeloproliferative Diseases; Melanoma; Leukemia, Lymphocytic, Chronic, B-Cell; Carcinoma, Non-Small-Cell Lung; Leukemia, Large Granular Lymphocytic; Myeloproliferative Disorders; Leukemia, Myeloid; Leukemia; Ependymoma; Leukemia, Myelogenous, Chronic; Solid tumours; Hematologic Neoplasms; Intestinal Neoplasms; Head and Neck Neoplasms; Squamous Cell Carcinoma of Head and Neck; Carcinoma, Renal Cell; Lymphoma, T-Cell, Peripheral; Myelodysplastic Syndromes; Nasopharyngeal Neoplasms; Leukemia, Myelomonocytic, Chronic; Neoplasms; Small Cell Lung Carcinoma; Hodgkin Disease; Glioblastoma; | Details |
| Triclabendazole | EGA-230B; CGA-89317; NVP-EGA230 | Approved | Novartis Pharma Ag | Egaten, Fasinex, Triclathera | Iran | Fascioliasis | Novartis Pharma Ag | 1989-01-01 | Fascioliasis | Details |
| Decitabine | 5-aza-CdR; NSC-127716; AzadC; E-7373; DAC | Approved | Eisai Co Ltd | Dacogen, 达珂 | Mainland China | Myelodysplastic Syndromes | Mgi Pharma Inc | 2006-05-02 | Lymphoma, Non-Hodgkin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Vulvar Neoplasms; Lymphoma, Mantle-Cell; Neuroblastoma; Breast Neoplasms; Lymphoma, Follicular; Colorectal Neoplasms; Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative; Primary Myelofibrosis; Leukemia, Myeloid, Acute; Burkitt Lymphoma; Lung Neoplasms; Multiple Myeloma; Lymphoma; Thyroid Neoplasms; Anemia, Sickle Cell; Carcinoma, Non-Small-Cell Lung; Leukemia, Lymphocytic, Chronic, B-Cell; Myelodysplastic-Myeloproliferative Diseases; Neoplasm Metastasis; Thyroid Cancer, Papillary; Melanoma; Precancerous Conditions; Breast Neoplasms, Male; Leukemia, Myelomonocytic, Chronic; Leukemia, Promyelocytic, Acute; Liver Neoplasms; Leukemia, Myelogenous, Chronic; Leukemia; Purpura, Thrombocytopenic, Idiopathic; Lymphoma, B-Cell, Marginal Zone; Solid tumours; Thalassemia; Neutropenia; Esophageal Neoplasms; Myelodysplastic Syndromes; Leukemia, Myeloid, Accelerated Phase; Small Cell Lung Carcinoma; Myeloproliferative Disorders; Lymphoma, Large B-Cel | Details |
| Decitabine/Cedazuridine | ASTX-727-LD; ASTX-727-10; E-7727/decitabine; Decitabine/E7727; ASTX-727 | Approved | Astex Pharmaceuticals Inc, National Cancer Institute | INAQOVI, Inaqovi, Inqovi | United States | Myelodysplastic Syndromes | Otsuka Pharmaceutical Co Ltd | 2020-07-07 | Leukemia, Myelogenous, Chronic; Leukemia; Solid tumours; Myelodysplastic Syndromes; Leukemia, Myelomonocytic, Chronic; Neoplasms; Triple Negative Breast Neoplasms; Mesothelioma; Breast Neoplasms; Leukemia, Myeloid, Acute; Glioma; Nervous System Neoplasms; Neurilemmoma | Details |
| Mecobalamin | E-0302 | Approved | Myelogen, Naso B12, NASOCOBAL, Methycobal, 弥尔神, 悦敏兴, RHINOCOBAL, 奇信, 曲力, 弥可保 | Peripheral Nervous System Diseases; Autistic Disorder; Neuritis; Neuralgia; Vitamin B 12 Deficiency; Amyotrophic Lateral Sclerosis; Fibromyalgia | Details | |||||
| Azacitidine | NSC-102816; 5-aza-CR; CC-486; NS-17; U-18496; NEX-18; NEX-18a | Approved | Celgene Corp | 维达莎, Vidaza, Onureg | United States | Myelodysplastic Syndromes | Bristol-Myers Squibb Company | 2004-05-19 | Leukemia, Myeloid, Acute; Immune System Diseases; Prostatic Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Breast Neoplasms; Osteosarcoma; Sarcoma; Brain Neoplasms; Tuberculosis, Pulmonary; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Primary Myelofibrosis; Hepatic Insufficiency; Multiple Myeloma; Lymphoma; Leukemia, Myelomonocytic, Juvenile; Lymphoma, Non-Hodgkin; Thyroid Neoplasms; Lung Neoplasms; Myelodysplastic-Myeloproliferative Diseases; Melanoma; Leukemia, Lymphocytic, Chronic, B-Cell; Carcinoma, Non-Small-Cell Lung; Leukemia, Large Granular Lymphocytic; Myeloproliferative Disorders; Leukemia, Myeloid; Leukemia; Ependymoma; Leukemia, Myelogenous, Chronic; Solid tumours; Hematologic Neoplasms; Intestinal Neoplasms; Head and Neck Neoplasms; Squamous Cell Carcinoma of Head and Neck; Carcinoma, Renal Cell; Lymphoma, T-Cell, Peripheral; Myelodysplastic Syndromes; Nasopharyngeal Neoplasms; Leukemia, Myelomonocytic, Chronic; Neoplasms; Small Cell Lung Carcinoma; Hodgkin Disease; Glioblastoma; | Details |
| Triclabendazole | EGA-230B; CGA-89317; NVP-EGA230 | Approved | Novartis Pharma Ag | Egaten, Fasinex, Triclathera | Iran | Fascioliasis | Novartis Pharma Ag | 1989-01-01 | Fascioliasis | Details |
| Decitabine | 5-aza-CdR; NSC-127716; AzadC; E-7373; DAC | Approved | Eisai Co Ltd | Dacogen, 达珂 | Mainland China | Myelodysplastic Syndromes | Mgi Pharma Inc | 2006-05-02 | Lymphoma, Non-Hodgkin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Vulvar Neoplasms; Lymphoma, Mantle-Cell; Neuroblastoma; Breast Neoplasms; Lymphoma, Follicular; Colorectal Neoplasms; Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative; Primary Myelofibrosis; Leukemia, Myeloid, Acute; Burkitt Lymphoma; Lung Neoplasms; Multiple Myeloma; Lymphoma; Thyroid Neoplasms; Anemia, Sickle Cell; Carcinoma, Non-Small-Cell Lung; Leukemia, Lymphocytic, Chronic, B-Cell; Myelodysplastic-Myeloproliferative Diseases; Neoplasm Metastasis; Thyroid Cancer, Papillary; Melanoma; Precancerous Conditions; Breast Neoplasms, Male; Leukemia, Myelomonocytic, Chronic; Leukemia, Promyelocytic, Acute; Liver Neoplasms; Leukemia, Myelogenous, Chronic; Leukemia; Purpura, Thrombocytopenic, Idiopathic; Lymphoma, B-Cell, Marginal Zone; Solid tumours; Thalassemia; Neutropenia; Esophageal Neoplasms; Myelodysplastic Syndromes; Leukemia, Myeloid, Accelerated Phase; Small Cell Lung Carcinoma; Myeloproliferative Disorders; Lymphoma, Large B-Cel | Details |
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| Curcumin | VOLT-03; VOLT-3; NSC-32982 | Phase 3 Clinical | University Of Pennsylvania | Neuralgia; Asthma; Cigarette Smoking; Uterine Cervical Dysplasia; Cervical Intraepithelial Neoplasia; Primary Myelofibrosis; Periapical Diseases; Dentist-Patient Relations; Colorectal Neoplasms; Lymphoma, T-Cell, Cutaneous; Cognitive Dysfunction; Pancytopenia; Breast Neoplasms; Prostatic Neoplasms; Oral Submucous Fibrosis; Tobacco Use Disorder; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Urinary Incontinence, Urge; Adenocarcinoma, Mucinous; Lung Neoplasms; Lichen Planus, Oral; Renal Insufficiency, Chronic; Osteoarthritis; Carcinoma, Non-Small-Cell Lung; Crohn Disease; Adenocarcinoma; Aortic Aneurysm, Abdominal; Thrombocythemia, Essential; Uterine Cervical Neoplasms; Stomatitis; Neoplasm Metastasis; Macular Degeneration; Condylomata Acuminata; Rectal Neoplasms; Arthritis, Rheumatoid; Pain; Spasm; Polycythemia Vera; Radiodermatitis; Digestive System Diseases; Diabetes Mellitus, Type 2; Metabolic Dysfunction-Associated Steatotic Liver Disease; Proteinuria; Gastritis, Atrophic; Depression; Optic Atrophy, Here | Details |
| Azacitidine/Cedazuridine | ASTX-030 | Phase 3 Clinical | Otsuka Pharmaceutical Co Ltd | Leukemia, Myelogenous, Chronic; Myelodysplastic Syndromes; Leukemia, Myeloid, Acute | Details |
| Guadecitabine Sodium | SGI-110; S-110; 0RB89YH367 (UNII code) | Phase 3 Clinical | Otsuka Holdings Co Ltd | Klatskin Tumor; Adenocarcinoma; Carcinoma, Non-Small-Cell Lung; Melanoma; Paraganglioma; Carcinoma, Hepatocellular; Gallbladder Neoplasms; Lung Neoplasms; Leukemia, Myeloid, Acute; Fallopian Tube Neoplasms; Colorectal Neoplasms; Peritoneal Neoplasms; Gastrointestinal Stromal Tumors; Cholangiocarcinoma; Chondrosarcoma; Prostatic Neoplasms, Castration-Resistant; Myeloproliferative Disorders; Small Cell Lung Carcinoma; Pancreatic Neoplasms; Carcinoma, Transitional Cell; Myelodysplastic Syndromes; Leukemia, Myelomonocytic, Chronic; Stomach Neoplasms; Pheochromocytoma; Carcinoma, Renal Cell; Kidney Neoplasms; Ovarian Neoplasms | Details |
| EF-009 | EF-009 | Phase 2 Clinical | Everfront Biotech Co Ltd | Pancreatic Neoplasms | Details |
| Fluorocyclopentenylcytosine | FCPEC; RX-3117; TV-1360; PCS-3117; RX 3117 | Phase 2 Clinical | Rexahn Pharmaceuticals Inc | Solid tumours; Pancreatic Neoplasms; Urinary Bladder Neoplasms | Details |
| FdCyd | NSC-48006; Ro-5-1090 | Phase 2 Clinical | City Of Hope National Medical Center, National Cancer Institute | Head and Neck Neoplasms; Esophageal Neoplasms; Neoplasms; Small Cell Lung Carcinoma; Myelodysplastic Syndromes; Urinary Bladder Neoplasms; Mesothelioma; Breast Neoplasms; Lung Neoplasms; Leukemia, Myeloid, Acute; Carcinoma, Non-Small-Cell Lung | Details |
| Azacitidine (Boryung Pharmaceutical) | Phase 2 Clinical | Boryung Pharmaceutical Co Ltd | Neoplasms | Details | |
| Decitabine/Tetrahydrouridine (EpiDestiny/Novo Nordisk) | EPI-01; EPI01; NN 7533 | Phase 2 Clinical | Epicdestiny | Anemia, Sickle Cell | Details |
| NTX-301 | NTX-303 | Phase 1 Clinical | Southern Research Institute, Pinotbio Inc | Solid tumours; Ovarian Neoplasms; Neoplasms; Carcinoma, Transitional Cell; Leukemia, Myelomonocytic, Chronic; Myelodysplastic Syndromes; Glioma; Leukemia, Myeloid, Acute | Details |
| Curcumin | VOLT-03; VOLT-3; NSC-32982 | Phase 3 Clinical | University Of Pennsylvania | Neuralgia; Asthma; Cigarette Smoking; Uterine Cervical Dysplasia; Cervical Intraepithelial Neoplasia; Primary Myelofibrosis; Periapical Diseases; Dentist-Patient Relations; Colorectal Neoplasms; Lymphoma, T-Cell, Cutaneous; Cognitive Dysfunction; Pancytopenia; Breast Neoplasms; Prostatic Neoplasms; Oral Submucous Fibrosis; Tobacco Use Disorder; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Urinary Incontinence, Urge; Adenocarcinoma, Mucinous; Lung Neoplasms; Lichen Planus, Oral; Renal Insufficiency, Chronic; Osteoarthritis; Carcinoma, Non-Small-Cell Lung; Crohn Disease; Adenocarcinoma; Aortic Aneurysm, Abdominal; Thrombocythemia, Essential; Uterine Cervical Neoplasms; Stomatitis; Neoplasm Metastasis; Macular Degeneration; Condylomata Acuminata; Rectal Neoplasms; Arthritis, Rheumatoid; Pain; Spasm; Polycythemia Vera; Radiodermatitis; Digestive System Diseases; Diabetes Mellitus, Type 2; Metabolic Dysfunction-Associated Steatotic Liver Disease; Proteinuria; Gastritis, Atrophic; Depression; Optic Atrophy, Here | Details |
| Azacitidine/Cedazuridine | ASTX-030 | Phase 3 Clinical | Otsuka Pharmaceutical Co Ltd | Leukemia, Myelogenous, Chronic; Myelodysplastic Syndromes; Leukemia, Myeloid, Acute | Details |
| Guadecitabine Sodium | SGI-110; S-110; 0RB89YH367 (UNII code) | Phase 3 Clinical | Otsuka Holdings Co Ltd | Klatskin Tumor; Adenocarcinoma; Carcinoma, Non-Small-Cell Lung; Melanoma; Paraganglioma; Carcinoma, Hepatocellular; Gallbladder Neoplasms; Lung Neoplasms; Leukemia, Myeloid, Acute; Fallopian Tube Neoplasms; Colorectal Neoplasms; Peritoneal Neoplasms; Gastrointestinal Stromal Tumors; Cholangiocarcinoma; Chondrosarcoma; Prostatic Neoplasms, Castration-Resistant; Myeloproliferative Disorders; Small Cell Lung Carcinoma; Pancreatic Neoplasms; Carcinoma, Transitional Cell; Myelodysplastic Syndromes; Leukemia, Myelomonocytic, Chronic; Stomach Neoplasms; Pheochromocytoma; Carcinoma, Renal Cell; Kidney Neoplasms; Ovarian Neoplasms | Details |
| EF-009 | EF-009 | Phase 2 Clinical | Everfront Biotech Co Ltd | Pancreatic Neoplasms | Details |
| Fluorocyclopentenylcytosine | FCPEC; RX-3117; TV-1360; PCS-3117; RX 3117 | Phase 2 Clinical | Rexahn Pharmaceuticals Inc | Solid tumours; Pancreatic Neoplasms; Urinary Bladder Neoplasms | Details |
| FdCyd | NSC-48006; Ro-5-1090 | Phase 2 Clinical | City Of Hope National Medical Center, National Cancer Institute | Head and Neck Neoplasms; Esophageal Neoplasms; Neoplasms; Small Cell Lung Carcinoma; Myelodysplastic Syndromes; Urinary Bladder Neoplasms; Mesothelioma; Breast Neoplasms; Lung Neoplasms; Leukemia, Myeloid, Acute; Carcinoma, Non-Small-Cell Lung | Details |
| Azacitidine (Boryung Pharmaceutical) | Phase 2 Clinical | Boryung Pharmaceutical Co Ltd | Neoplasms | Details | |
| Decitabine/Tetrahydrouridine (EpiDestiny/Novo Nordisk) | EPI-01; EPI01; NN 7533 | Phase 2 Clinical | Epicdestiny | Anemia, Sickle Cell | Details |
| NTX-301 | NTX-303 | Phase 1 Clinical | Southern Research Institute, Pinotbio Inc | Solid tumours; Ovarian Neoplasms; Neoplasms; Carcinoma, Transitional Cell; Leukemia, Myelomonocytic, Chronic; Myelodysplastic Syndromes; Glioma; Leukemia, Myeloid, Acute | Details |
This web search service is supported by Google Inc.
A-Z
